News

03 Sep: New AFib Guidelines Confront Underlying Illness

LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease. The identification and treatment of comorbidities and risk factors are the initial and central components of patient management…

03 Sep: Pause Anticoagulants During TAVI to Reduce Bleeding Risk

LONDON — Continuing oral anticoagulant drugs rather than briefly stopping them during transcatheter aortic valve implantation (TAVI) failed to provide any benefits and, in fact, increased the risk for bleeding, report trial investigators. The randomized controlled POPular PAUSE TAVI trial presented at the European Society of Cardiology Congress showed that patients randomly assigned to continuous

Experts develop global consensus document on atrial cardiomyopathy

02 Sep: Experts develop global consensus document on atrial cardiomyopathy

An international cardiology working group has published a consensus report on atrial cardiomyopathy in Europace. Twenty-one scientists from the rhythmological societies of Europe (European Heart Rhythm Association), North America (Heart Rhythm Society), South America (Latin American Heart Rhythm Society) and the Asia-Pacific region (Asia Pacific Heart Rhythm Society APHRS) were involved…